Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Health Care

Health Care

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Japan Approves AstraZeneca’s Two Treatments For Asthma, Rare Form Of Cancer

By Vandana Singh
September 27, 8:57 AM
Japan’s health agency has approved AstraZeneca Plc’s (NASDAQ:AZN) Koselugo (selumetinib) for pediatric patients with plexiform neurofibromas (PNs) in neurofibromatosis type 1…

AZN

Read More
6 minute read
  • Biotech
  • Cryptocurrency
  • General
  • Health Care
  • IPOs
  • Large Cap
  • Legal
  • M&A
  • Markets
  • Media
  • Movers
  • News
  • Penny Stocks
  • Social Media
  • Tech
  • Top Stories
  • Trading Ideas

Elon Musk Twitter Case Deposition Delayed, FTX US Goes Shopping, Spotify’s Analyst Sees Audiobooks Immaterial: Top Financial Media Stories Tuesday, Sept. 27

By Vandana Singh
September 27, 8:46 AM
Bloomberg

AAPL

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • Media
  • News

As Moderna Grapples With Supply Shortage, FDA Gives Nod To Additional Lots of COVID-19 Booster

By Vandana Singh
September 27, 6:47 AM
The FDA authorized an additional five batches of Moderna Inc’s (NASDAQ:MRNA) updated Covid booster shots made at Catalent Inc‘s (NYSE:CTLT) Indiana facility after…

BNTX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Legal
  • News

US Agency EEOC Files Lawsuit Against Eli Lilly Over Nationwide Age Discrimination

By Vandana Singh
September 27, 6:39 AM
The U.S. Equal Employment Opportunity Commission (EEOC) accused Eli Lilly And Co (NYSE:LLY) of illegally refusing to hire older workers for…

LLY

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Legal
  • News

Biogen Settles For $900M In Bribe Case For Prescribing Multiple Sclerosis Drugs

By Vandana Singh
September 27, 6:25 AM
Biogen Inc (NASDAQ:BIIB) has reached a $900 million settlement with a whistleblower who accused the firm of paying doctors bribes to…

BIIB

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Exicure Lays Off Two-Third Employees, Ceases R&D Activities

By Vandana Singh
September 27, 6:11 AM
Exicure Inc (NASDAQ:XCUR) announced restructuring plans and aligned resources to continue exploring strategic alternatives.  The company will cut its workforce by…

XCUR

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Legal
  • News

‘Biogen Agrees to Pay $900 Million Over Alleged Improper Physician Payments’ -WSJ

By Bill Haddad
September 26, 7:45 PM
https://www.wsj.com/articles/biogen-agrees-to-pay-900-million-over-alleged-improper-physician-payments-11664231855?mod=latest_headlines

BIIB

Read More
3 minute read
  • Biotech
  • Education
  • General
  • Health Care
  • Penny Stocks
  • Small Cap

If You Invested $1,000 In BioNano (BNGO) Stock At Its COVID-19 Pandemic Low, Here’s How Much You’d Have Now

By Wayne Duggan
September 26, 4:15 PM
Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.

BNGO

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • News
  • Small Cap

This Analyst Says Artivion’s Sell Off Seems Overdone After Trial Halt

By Vandana Singh
September 26, 3:31 PM
On Friday, Artivion Inc (NYSE:AORT) stopped the PROACT Xa clinical trial after the Data Safety Monitoring Board (DSMB) indicated that…

AORT

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • News
  • Penny Stocks
  • Price Target
  • Reiteration

Inventiva’s NASH Pact In China Represents ‘Financially Prudent Pathway,’ Says This Analyst

By Vandana Singh
September 26, 1:37 PM
Last week, Inventiva (NASDAQ:IVA) announced a licensing and collaboration agreement with Sino Biopharm’s subsidiary Chia Tai-Tianqing Pharmaceutical Group (CTTQ) to…

IVA

Posts pagination

Previous 1 … 402 403 404 … 478 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service